Community Research Initiative (CRI) is an independent, nonprofit community-based organization dedicated to leading the way in HIV/AIDS and hepatitis C clinical research, ensuring access to life-saving medications and providing financial assistance for approved drug treatments and health insurance coverage for those in need.
Since 1989, CRI has participated in some of the most promising HIV/AIDS medication research being conducted anywhere in the world. CRI added hepatitis C clinical research to its mission in 2013. Through its continued outreach efforts, CRI provides the latest treatment information to people living with HIV/AIDS including women, people of color and others who have been traditionally underserved. Through its efficient and comprehensive management of the Massachusetts HIV Drug Assistance Program (HDAP), CRI provides access to medications and health insurance coverage to over 8,000 of the state's most needy individuals.
CRI has produced critical research and drug testing data that has contributed to the FDA approval of nearly all of the currently available HIV treatments and some hepatitis C regimens. What CRI discovers from its advanced clinical research has the potential to help people all over the world who are living with HIV/AIDS and hepatitis C.